Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
ProKidney Corp
About PROK
Prokidney Corp. is a late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD). The Company’s cell therapy platform has the potential to treat CKD using a patient’s own cells. The Company’s lead product candidate, rilparencel (also known as REACT), is a first-in-class, patented, proprietary autologous cell therapy being evaluated in the ongoing Phase III REGEN-006 (PROACT 1) trial to demonstrate the therapy’s potential to preserve kidney function in patients with type 2 diabetes and advanced CKD. Its PROACT 1 is an ongoing Phase III randomized, blinded, sham controlled safety and efficacy study of rilparencel in subjects with type 2 diabetes and advanced CKD. Its REGEN-007 is a multi-center Phase II open-label, randomized two-arm trial of rilparencel in patients with diabetes, CKD.
Find out what a historical investment in ProKidney Corp would be worth today using our PROK stock calculator.
Market Capitalisation
$516.52M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
124
High today
$1.77
Low today
$1.63
Open price
$0.00
52-week high
$7.13
52-week low
$0.54
Ready to start your investing journey with Stake?
Open an accountHow do I buy PROK shares in Australia?
Buying PROK shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in ProKidney Corp in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PROK
What is the ticker symbol of ProKidney Corp?
The ticker symbol for ProKidney Corp is PROK.
How much is one share of PROK?
One share of PROK is valued at $1.69 as of 10 June 2026.
What is the market capitalisation of ProKidney Corp PROK?
As of 10 June 2026 ProKidney Corp has a market cap of $516.52M.
What is the 52-week high for ProKidney Corp stock?
The ProKidney Corp 52-week high stock price is $7.13.
What is the 52-week low for ProKidney Corp stock?
The ProKidney Corp 52-week low stock price is $0.54.
Can I buy PROK shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PROK shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PROK on Stake
- Buy PROK from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PROK from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PROK related stocks